Daniela Covaleda Cortes

Mrs. Daniela Covaleda Cortes

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 June 2025 in Chemico-Biological Interactions
Verified
Journal Article
Open access
RPRaquel Pequerul
Raquel Pequerul
DCDaniela Covaleda Cortes
Daniela Covaleda Cortes
ASAndrés S. Sánchez-Vaca
Andrés S. Sánchez-Vaca
LTLaura Torres
Laura Torres
ACAndrada Constantinescu
Andrada Constantinescu
JFJaume Farrés
Jaume Farrés
Aldehyde dehydrogenase (ALDH) isoforms are widely used as biomarkers and potential drug targets in cancer research. Quantitation of ALDH enzymatic activity in biological samples often relies on the use of commercially available assays that are quite unspecific and do not discriminate between the various ALDH isoforms. The availability of highly purified recombinant ALDH isoforms allowed us to perform a full kinetic characterization of ALDH isoforms with fluorogenic substrates, BODIPY™-aminoacetaldehyde (BAAA), the ALDEFLUOR™ assay reagent, and two naphthaldedyde derivatives, 6-methoxy-2-naphthaldehyde (MONAL-62) and 7-methoxy-1-naphthaldehyde (MONAL-71). All ALDH1A isoforms were active to different extend with BAAA, while ALDH3A1 did not show any activity. Remarkable kinetic differences between ALDH1A1, ALDH1A2, ALDH1A3, ALDH2 and ALDH3A1 were observed with naphthaldehyde derivatives. Exquisite sensitivity was attained with MONAL-62 with a lower detection limit of 2 amol or 106 molecules of enzyme per microliter for ALDH1A1. The high substrate specificity of ALDH1A1 for MONAL-71 provides an alternative assay for the unambiguous identification of this isoform. Enzymatic properties of isoforms were accounted for by in silico simulations of substrate docking to the active site of ALDH structures. In addition to substrate specificity, inhibitor selectivity of each isoform, as assessed by incubation with DIMATE and ABD0171 inhibitors, provided additional information about isoform composition in low-activity samples isolated from cell extracts. The method was successfully applied to the detection of ALDH isoform activity in triple-negative breast cancer cells.

Verified
Journal Article
Open access
PDF file
MTMartha de la Caridad Vives Hernández de la Torre
Martha de la Caridad Vives Hernández de la Torre
GCGiovanni Covaleda Cortés
Giovanni Covaleda Cortés
LMLaura Montesinos
Laura Montesinos
DCDaniela Covaleda Cortes
Daniela Covaleda Cortes
JOJuan C. Ortiz
Juan C. Ortiz
Francesc Xavier AvilesFrancesc Xavier Aviles
Francesc Xavier Aviles
Protease inhibitors are biomolecules with growing biotechnological and biomedical relevance, including those derived from plants. This study investigated strong trypsin inhibitors in quinoa, amaranth, and lupine seeds, plant grains traditionally used in Andean South America. Amaranth seeds displayed the highest trypsin inhibitory activity, despite having the lowest content of aqueous soluble and thermostable protein material. This activity, directly identified by enzymatic assay, HPLC, intensity-fading mass spectrometry (IF-MS), and MS/MS, was attributed to a single protein of 7889.1 Da, identified as identical in Amaranthus caudatus and A. hybridus, with a Ki of 1.2 nM for the canonical bovine trypsin. This form of the inhibitor, which is highly homogeneous and scalable, was selected, purified, and structurally–functionally characterized due to the high nutritional quality of amaranth seeds as well as its promising agriculture–biotech–biomed applicability. The protein was crystallized in complex with bovine trypsin, and its 3D crystal structure resolved at 2.85 Å, revealing a substrate-like transition state interaction. This verified its classification within the potato I inhibitor family. It also evidenced that the single disulfide bond of the inhibitor constrains its binding loop, which is a key feature. Cell culture assays showed that the inhibitor did not affect the growth of distinct plant microbial pathogen models, including diverse bacteria, fungi, and parasite models, such as Mycoplasma genitalium and Plasmodium falciparum. These findings disfavour the notion that the inhibitor plays an antimicrobial role, favouring its potential as an agricultural insect deterrent and prompting a redirection of its functional research.

17 June 2026 in Chemico-Biological Interactions
Verified
Journal Article
Open access
RPRaquel Pequerul
Raquel Pequerul
DCDaniela Covaleda Cortes
Daniela Covaleda Cortes
ASAndrés S. Sánchez-Vaca
Andrés S. Sánchez-Vaca
TBTarik Benali
Tarik Benali
ICIsmail Ceylan
Ismail Ceylan
JFJaume Farrés
Jaume Farrés
Aldehyde dehydrogenase (ALDH) isoforms are crucial for cellular detoxification and metabolic regulation, yet their enzymatic properties with non-canonical substrates remain underexplored. ALDH1A isoforms are overexpressed in several cancer types and contribute to tumor aggressiveness and chemoresistance. In this study, we characterize the esterase activity of ALDH1A isoforms using novel resorufin-derived fluorogenic substrates. Steady-state kinetic analysis reveals distinct catalytic efficiencies (kcat/Km) among isoforms, emphasizing differences in substrate hydrolysis rates and binding affinities. Structural modeling and fluorescence-based assays indicate that NAD+ binding induces conformational rearrangements that modulate esterase activity. Resorufin-derived esters clearly outperformed 4-nitrophenyl acetate and standard aldehyde substrates of ALDH. These findings provide mechanistic insights into ALDH1A isoform selectivity and expand the application of resorufin-based probes for ALDH functional assays. Our study establishes a foundation for developing targeted ALDH assays and potential applications in cancer drug screening and biomarker discovery.

15 July 2026 in bioRxiv
Verified
Preprint
Open access
DCDaniela Covaleda Cortes
Daniela Covaleda Cortes
DVDavid Vizarraga
David Vizarraga
TUTulsi Upadhyay
Tulsi Upadhyay
JZJiyun Zhu
Jiyun Zhu
DADaniel Abegg
Daniel Abegg
JFJaume Farrés
Jaume Farrés
Aldehyde dehydrogenases (ALDH) are enzymes that catalyze the NAD(P) + -dependent oxidation of aldehydes into carboxylic acids, playing roles in detoxification, biosynthesis, and regulatory functions. Dysfunction of ALDH is associated with serious conditions such as alcohol intolerance, cancer, cardiovascular problems, and neurological disorders. In humans, ALDH1A1 and ALDH1A3 isoforms act as retinaldehyde dehydrogenases and are overexpressed in various cancers, where high levels are associated with increased tumor malignancy, cancer stem cell traits, and therapeutic resistance. ALDH1A3 is recognized as a promising target for anticancer therapies, with several inhibitors, mainly reversible, developed to specifically target it or the enzyme family. Since ALDH enzymes can also display esterase activity, we used this property to develop an in vitro assay specifically targeting the esterase function of ALDH1A3. A highly conserved active-site cysteine in ALDH1A3 is located at the bottom of two converging channels, which define the substrate- and cofactor-binding pockets. To target this catalytic cysteine, we screened a library of 3,200 cysteine-focused covalent fragments. This led to the identification of Z3405279217 (Z34), an acrylamide-based covalent compound that inhibits both ALDH1A1 and ALDH1A3 at sub-micromolar levels. Biochemical and biophysical tests confirmed that Z34 acts as a time-dependent, covalent, and irreversible binder to the active-site cysteine. In this work, we determined the Cryo-EM structure of the ALDH1A3-Z34 complex at 2.26 Å resolution, confirming the covalent attachment to the catalytic cysteine of Z34. Notably, two mutually exclusive covalent binding modes were observed: one occupying the substrate-binding pocket and the other the cofactor-binding region. Z34 displayed unexpected binding modes within the active site and holds promise as a lead compound for future drug development. GRAPHICAL

23 October 2026 in ChemRxiv
Verified
Preprint
Open access
RPRaquel Pequerul
Raquel Pequerul
DCDaniela Covaleda Cortes
Daniela Covaleda Cortes
MSMarc Serveto
Marc Serveto
Sebastian TancoSebastian Tanco
Sebastian Tanco
JLJulia Lorenzo
Julia Lorenzo
MCMarina Corbella
Marina Corbella
Aldehyde dehydrogenase 1A (ALDH1A) enzymes play central roles in retinoic acid signaling and cancer stem cell biology, yet the molecular determinants governing isoform-selective covalent inhibition remain poorly understood. Here we investigate the binding and reactivity of the activated alkyne inhibitor S-methyl-4-(dimethylamino)-4-methylpent-2-ynethioate (DIMATE), a potent, irreversible inhibitor of ALDH1A currently in phase I clinical trials. Using QM/MM metadynamics simulations based on high-resolution crystal structures, enzyme kinetics and site-directed mutagenesis, we found that active-site cysteine reactivity and cofactor-binding channel occupancy control whether the inhibitor binds reversibly or irreversibly to the ALDH1A3 isoform. We identified two reaction pathways initiated by nucleophilic attack from the catalytic Cys314: transthioesterification at the carbonyl carbon and α-addition to the alkyne. Only the α-addition leads to irreversible inhibition, a process that critically depends on a vicinal cysteine (Cys313) acting as a proton donor. Consistently, experiments show that ALDH1A isoforms lacking this neighboring cysteine, as well as Cys313Ala mutants, display exclusively reversible inhibition. NAD+ binding further modulates reactivity by disfavoring α-addition and promoting hydrolysis of DIMATE to a non-inhibitory carboxylic acid product, establishing NAD+ as a switch between irreversible covalent modification and reversible turnover. Together, these results reveal how vicinal cysteine chemistry and cofactor-dependent activesite dynamics govern covalent reactivity in ALDH1A enzymes, providing a basis for the rational design of isoform-selective covalent inhibitors targeting cancer-associated ALDH enzymes.

19 December 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
MTMartha de la Caridad Vives Hernández de la Torre
Martha de la Caridad Vives Hernández de la Torre
GCGiovanni Covaleda Cortés
Giovanni Covaleda Cortés
LMLaura Montesinos
Laura Montesinos
DCDaniela Covaleda Cortes
Daniela Covaleda Cortes
JOJuan C. Ortiz
Juan C. Ortiz
Francesc Xavier AvilesFrancesc Xavier Aviles
Francesc Xavier Aviles
Protein protease inhibitors are biomolecules with growing biological, biotechnological and biomedical relevance, including those derived from plants. In this work, we compared by Intensity-Fading.Mass Spectrometry (IF-MS) and other approaches the occurrence of strong protein protease inhibitors against trypsin-type enzymes in seeds from plants of quinoa, amaranth and lupine traditionally used in South America. We differentially found that although amaranth seeds have the smaller quantity of aqueous soluble and thermostable protein material, they show the highest level of trypsin inhibitory capability among them. Such property was directly assigned by HPLC, MS/MS and activity measurements of the seed extracts to a single protein form of 7889.1 Da. It appeared identical in two studied amaranth variants, Amaranthus caudatus and A. hybridus, showing in both a Ki of 1.24nM for the canonical bovine trypsin. The high homogeneity and easy scalability found for this protein form, together with the outstanding nutritional quality of its seeds, prompted us to further structurally and functionally analyse it. This form succesfully crystallised with the above enzyme. The 3D structure of the complex, solved at 2.8 Å resolution by X-ray crystallography, displayed the inhibitor and enzyme trapped in a substrate-like transition state mode, unveiling the structure-function basis of the inhibitory and specific interactions. It verified that this trypsin inhibitor can be classified within the potato-I structural family, with its single disulfide constraining the binding loop as a key feature. Cell culture studies showed that the inhibitor addition is not affecting the cell growth capability of distinct plant microbial pathogen models, as diverse bacteria and fungi, or parasite models such as Mycoplasma genitalium and Plasmodium falciparum. Such overall behaviour seems to disfavour a role of the inhibitor as antimicrobial, and in potentially related agricultural/biotech/biomed uses, and suggests the convenience to redirect its functional and applicative research towards insect deterrence.